Study #2020-0517
A RANDOMIZED PHASE II TRIAL OF PALLIATIVE PELVIC RADIATION THERAPY TO IMPROVE HEALTH RELATED QUALITY OF LIFE IN GYNECOLOGIC MALIGNANCIES
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This phase II trial studies if a single session of palliative radiation therapy can help improve symptoms of gynecologic cancers that have spread to other places in the body (metastatic) and that affect quality of life as well or more so than multiple sessions (which is the standard of care). Palliative radiation therapy may help patients with metastatic gynecologic cancers live more comfortably. Researchers also want to learn how radiation affects the immune system and to compare the effects of giving one radiation treatment to giving multiple radiation treatments.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Metastatic Malignant Female Reproductive System Neoplasm
Study phase:
Phase II
Physician name:
Lauren Colbert
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.